Feinberg Peter 4
4 · Immuneering Corp · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Feinberg Peter
Director
Transactions
- Purchase
Class A Common Stock
2024-03-18$2.31/sh+45,024$103,857→ 56,790 total - Purchase
Class A Common Stock
2024-03-18$3.05/sh+4,976$15,201→ 61,766 total - Purchase
Class A Common Stock
2024-03-19$2.56/sh+25,000$64,000→ 86,766 total
Holdings
- 476,615(indirect: By LLC)
Class A Common Stock
- 115,441(indirect: By LLC)
Class A Common Stock
- 392,242(indirect: General Partner of PF Associates L.P.)
Class A Common Stock
Footnotes (2)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.96 to $2.9499. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.9863 to $3.1799. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.